A multiscale biohybrid strategy using biostable and biodegradable polymers to develop a growth-accommodating heart valved conduit for children

Biomedical Technology · Published 2026-06-10 · DOI 10.1016/j.bmt.2026.100153

Free full text

Authors (11)

Senay Ustunel, Halil Beqaj, Kavya Rajesh, Mingze Sun, V. Reed LaSala, Amanda Ooi, Sophia Jackman, Gerardo Ramos-Lemos, Elizabeth Cordoves, Andrea Tonelli, David M. Kalfa

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Ustunel, S., Beqaj, H., Rajesh, K., et al. (2026). A multiscale biohybrid strategy using biostable and biodegradable polymers to develop a growth-accommodating heart valved conduit for children. Biomedical Technology. https://doi.org/10.1016/j.bmt.2026.100153

Related articles

• Adoptive cell therapy for HBV-associated liver diseases · Biomedical Technology · 2025 · Same journal
• Ordered micro-nano structured biomaterials for wound healing · Biomedical Technology · 2024 · Same journal
• Advanced 3D biomaterials and bioprinting strategies for in vitro modeling of neurodegenerative diseases · Biomedical Technology · 2025 · Same journal
• Integrated tardigrade-based biomimetic strategy and stem cell expansion and differentiation for a novel radioprotection approach · Biomedical Technology · 2026 · Same journal
• Next-generation 3D bioprinted inner ear organoids · Biomedical Technology · 2026 · Same journal
• De novo design strategies of nanomedicines for antigen-specific immune tolerance modulation · Biomedical Technology · 2026 · Same journal
• Wireless bioelectric stimulation for bone regeneration using magnetoelectric PVDF/BaTiO3 – Fe80Ga20 laminates · Biomedical Technology · 2025 · Same journal
• Biocompatible screw-based biomechanical alignment technique for improving surgical effect in adolescent flexible flatfoot · Biomedical Technology · 2026 · Same journal
• Emerging strategies for the treatment of endometriosis · Biomedical Technology · 2024 · Same journal
• Redox-responsive carrier-free nanoassemblies enable dual topoisomerase I/II inhibition for metastasis-suppressed breast cancer therapy · Biomedical Technology · 2026 · Same journal